Ivabradine exercise tolerance trial
- Conditions
- Heart failure
- Registration Number
- JPRN-jRCTs031200281
- Lead Sponsor
- Shiga Tsuyoshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Patients who are 20 years of age or more with chronic heart failure in New York Heart Association functional classes II and III, a left ventricular ejection fraction lower than 40%, and a resting heart rate of 75 beats per minute or higher in sinus rhythm despite optimal medical therapy for heart failure including beta-blockers.
Patients with congenital heart disease, severe valvular diseases, active myocarditis, myocardial infarction within the previous 8 weeks, ventricular or atrioventricular pacing >40% of 24 hours, persistent atrial fibrillation or flutter, or symptomatic hypotension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method